Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia-Reference-Cited by-同舟云学术

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia

Published:2024-05-15 Issue:9 Volume:65 Page:1325-1334
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Marvin-Peek Jennifer¹^ORCID,Jen Wei-Ying¹^ORCID,Kantarjian Hagop M.¹^ORCID,McCue David¹,Haddad Fadi G.¹,Wierda William¹,Ferrajoli Alessandra¹,Burger Jan¹,Abusab Tareq²,Jorgensen Jeffrey³^ORCID,Wang Sa A.³,Patel Keyur³,Loghavi Sanam³,O’Brien Susan⁴,Ravandi Farhad¹^ORCID

Affiliation:

1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

2. Department of Hematology and Oncology, Baylor College of Medicine, Houston, TX, USA

3. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

4. Department of Medicine, UCI Health Chao Family Comprehensive Cancer Center, Orange, CA, USA

Funder

Charif Souki Cancer Research Fund

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2349700

Reference28 articles.

1. Clinical manifestations and infectious complications of hairy-cell leukaemia

2. Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients

3. BRAFMutations in Hairy-Cell Leukemia

4. Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia

5. BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. It’s time to change the standard of care for hairy cell leukemia?!;Leukemia & Lymphoma;2024-07-05